Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

manufacturing

manufacturing is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 5
News articles 1
Drug details — manufacturing
Class
—
Route
—
Patents
20
Programs
5
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

manufacturing is an FDA-listed pharmaceutical active ingredient.

Key facts

INN manufacturing

Approval history

Authority Status Date
NMPA clinical trials —

Recent coverage

View all news
Pharma Manufacturing World 2026: Key Insights and Expectations
High impact AnalysisMay 21, 2026

Pharma Manufacturing World 2026: Key Insights and Expectations

3 min

As Pharma Manufacturing World 2026 approaches, key insights and expectations are emerging. This article previews the event's agenda, key players, and potential catalysts.

Dr. Sarah Mitchell

Pipeline programs

Browse pipeline
  1. 72189812 Phase 3 · Anaxis Pharma · Bipolar I Disorder
  2. LIOTHYRONINE for Hypothyroidism Triiodothyronine… Phase 3 · Disc Medicine · Hypothyroidism Triiodothyronine Quality of Life Persistant c
  3. BOSUT-09-24 Phase 1 · Anaxis Pharma · myeloid leukemia
  4. IMATI-10-25 Phase 1 · Anaxis Pharma · Acute Lymphoblastic Leukemia (Ph+ ALL), (Ph+) Chronic Myeloi
  5. MS700623_0061 Phase 1 · MSD Merck Sharp · Infertility

Related patents

Browse patents

  1. US 12304900

    Islet cell manufacturing compositions and methods of use

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12291058

    Dispersions for additive manufacturing comprising discrete carbon nanotubes

    Expires Mon May 01 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12251428

    Hydrogel composition, hydrogel biomedical material, method for facilitating regeneration of bone and manufacturing method of hydrogel composition

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12230379

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12230378

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Expires Mon Feb 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12170134

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12159700

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12150461

    Nicotinamide adenine dinucleotide (NAD) compositions, methods of manufacturing thereof, and methods of use thereof

    Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11964003

    Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11957736

    Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11945795

    Islet cell manufacturing compositions and methods of use

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11701307

    Organic-inorganic composite particles, manufacturing method therefor, and cosmetic

    Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11631483

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. IL 300192

    Manufacturing of dimeric contrast agents

    Expires Tue Feb 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11576951

    Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same

    Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11446360

    High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same

    Expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11161826

    Manufacturing methods and polymorphs of a thiazoline anti-hyperalgesic agent

    Expires Mon Oct 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11058671

    Formulations and methods of manufacturing formulations for use in colonic evacuation

    Expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11028162

    Methods for manufacturing activatable binding polypeptides comprising matrix metalloprotease cleavable moieties

    Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10940626

    Manufacturing of small film strips

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is manufacturing?

manufacturing is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.